N
SQZ

Nuveen’s SQZ Biotechnologies Company SQZ Stock Holding History

Nuveen’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-77,754
Closed -$370K – 3574
2022
Q1 		$370K Buy
77,754
+1,347
+2% +$8.55K ﹤0.01% 3082
2021
Q4 		$762K Sell
76,407
-6,043
-7% -$74.1K ﹤0.01% 2947
2021
Q3 		$1.19M Sell
82,450
-2,729
-3% -$37K ﹤0.01% 2924
2021
Q2 		$1.23M Buy
+85,179
New +$1.11M ﹤0.01% 2928
2021
Q1 		– Sell
-7,308
Closed -$212K – 3411
2020
Q4 		$212K Buy
+7,308
New +$187K ﹤0.01% 3191

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen's SQZ Position: Q2 2022 in Review

Nuveen sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 77,754 shares — an estimated $370K sold.

Nuveen first reported a position in SQZ in Q4 2020 and held it in 5 quarters. The position peaked at $1.23M in Q2 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

  • Nuveen reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 77,754 SQZ Biotechnologies Company shares in Q2 2022, an estimated $370K.
  • Nuveen first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 5 quarters.
  • Nuveen's SQZ Biotechnologies Company position peaked at $1.23M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.